SCHEMBL1133233

SCHEMBL1133233

NCCCc1nc(-c2cccnc2)c[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 7/20 0.47
CYP2C9 P11712 3/20 0.43
CYP2B6 P20813 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP2D6 P10635 2/20 0.43
IDO1 P14902 1/20 0.43
HRH1 P35367 2/20 0.42
MAPK1 P28482 2/20 0.42
LOXL2 Q9Y4K0 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
PTK2 Q05397 1/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2E1 P05181 2/20 0.41
AURKA O14965 1/20 0.40
TTK P33981 1/20 0.40
AURKB Q96GD4 1/20 0.40
INCENP Q9NQS7 1/20 0.40
PDGFRB P09619 1/20 0.40
METAP2 P50579 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2323022 0.96 HRH1 (0.48) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL455756 0.86 MAPK1 (0.42) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL16458131 0.83 MAPK1 (0.40) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL11097956 0.83 SSTR1 (0.43) LOXL2ALDH1A1
SCHEMBL5025500 0.82 MAPK1 (0.43) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL7686070 0.82 MAPK1 (0.43) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL6570950 0.82 MAPK1 (0.39) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL1928646 0.81 AKT2 (0.42) LOXL2ALDH1A1
SCHEMBL7683895 0.80 MAPK1 (0.42) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL19323015 0.79 CYP2A6 (0.46) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2287173-A1 10A-AZALIDE COMPOUND HAVING 4-MEMBERED RING STRUCTURE Taisho Pharmaceutical Co., Ltd. (JP) 2011-02-23 EP disclosed